Pre-anthracycline echocardiogram rarely changes treatment strategy in acute myeloid leukemia

Am J Hematol. 2018 Jun;93(6):E144-E146. doi: 10.1002/ajh.25083. Epub 2018 Apr 11.

Authors

John Ogden¹, Jennifer Yui¹, Walid Ali², Mythri Mudireddy², Aref Al-Kali², Mrinal Patnaik², Naseema Gangat², Michelle Elliott², William Hogan², Christopher Hook², Alexandra Wolanskyj-Spinner², Animesh Pardanani², Hector Villarraga³, Mark Litzow², Ayalew Tefferi², Kebede Begna²

Affiliations

¹ Department of Internal Medicine, Mayo Clinic, Rochester, Minnesota.
² Division of Hematology, Department of Internal Medicine and, Mayo Clinic, Rochester, Minnesota.
³ Department of Cardiovascular Medicine, Mayo Clinic, Rochester, Minnesota.

PMID: 29508441
DOI: 10.1002/ajh.25083

No abstract available

Publication types

Letter

MeSH terms

Adolescent
Adult
Aged
Aged, 80 and over
Anthracyclines / therapeutic use*
Echocardiography / methods*
Humans
Leukemia, Myeloid, Acute / physiopathology*
Leukemia, Myeloid, Acute / therapy
Middle Aged
Stroke Volume
Young Adult

Substances

Anthracyclines